Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More
you are here: HomeNewsIndia

COVID-19 surge | Govt waives customs duty on Remdesivir API, injection

The move comes days after the Centre approved the stepping up of Remdesivir's domestic production. The export of the drug was also placed under an interim ban on April 11.

April 21, 2021 / 07:26 AM IST
Vial of Remdesivir (File image: Reuters)

Vial of Remdesivir (File image: Reuters)

The customs duty on imported Remdesivir injections and the drug's active pharmaceutical ingredients (API) has been waived, the Centre announced on April 20.

The move is aimed at facilitating the enhanced imports of Remdesivir - the anti-viral medication whose demand has shot up in India since the county was hit by the second wave of the pandemic.

The central government has also exempted customs duty on the import of "Beta Cyclodextrin (SBEBCD)", used in the manufacture of Remdesivir, subject to the condition that the importer follows the procedure set out in the Customs (Import of Goods at Concessional Rate of Duty) Rules, 2017, stated an official release issued by the Union Ministry of Finance.

The move comes days after the Centre approved the stepping up of domestic production of Remdesivir.

Also read: Remdesivir production to be increased to up to 78 lakh vials per month: Centre

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

In the meetings held with all the existing manufacturers of the Remdesivir drug, a decision was taken to "increase production/supply and reduce prices of Remdesivir", Union Minister of State Mansukh Mandaviya said on April 14.

The current total installed capacity of the seven manufacturers of Remdesivir is 38.80 lakh vials per month. Fast-track approval has been given for seven additional sites having the production capacity of 10 lakh vials per month to six manufacturers, said a statement issued by the Union Ministry of Chemicals and Fertilisers on April 14.

"Another 30 lakh vials per month production is lined up. This would ramp up the capacity for manufacturing to around 78 lakh vials per month," the statement added.

As an additional measure, Remdesivir, API and formulation were placed under export ban on April 11 to increase the supply of Remdesivir in the domestic market.

The states in India with a high caseload have demanded the Centre to expedite the supply of Remdesivir. Maharashtra Chief Minister Uddhav Thackeray stated on April 13 that the state currently requires 40,000-50,000 injections per day.
Moneycontrol News
first published: Apr 20, 2021 10:24 pm

stay updated

Get Daily News on your Browser
Sections